Close
ACHEMA MIDDLE EAST 2026

New Endometrial Cancer Care Phase II Results Encouraging

The most recent trial of a new antibody drug that goes on to deliver potent chemotherapy that too directly to the cancer cells for...

Duality Keeps An Eye Out For Hong Kong IPO For ADC Trials

Duality Biotherapeutics from China has gone ahead and filed paperwork as far as a Hong Kong IPO is concerned, thereby looking out for an...

Clario joins forces with Mobilise-D to advance Digital Mobility Outcomes in clinical trials

Clario, a leading provider of technologies and endpoint data solutions for clinical trials announced the enhancement of its digital capture of patient mobility data...

Recursion, Exscientia Unite For $850M, 10 Trials In 18 Months

The resultant biotech, which the businesses announced on Thursday, would have a pipeline that may produce 10 clinical readouts over the next 18 months,...

The Role of Partnerships In Managing Clinical Trial Costs

Running a clinical study entails significant costs and necessitates collaboration among sponsors, vendors, CROs, and sites to ensure trial success. At the 13th Annual Clinical...

Insights Into $3.72B Clinical Trial Supplies Market By 2028

The market for clinical trial supplies has shown strong growth recently, expanding from $2.52 billion in 2023 to $2.75 billion in 2024, with a...

New FDA Guidance To Enhance Diversity In Clinical Trials

The FDA has made progress in promoting diversity in clinical trials. Recently, the agency published a draft guidance providing more information on how sponsors...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...